Evaluate the safety and efficacy of the new drug Latrunculin.
Over 40 years old, diagnosed with Primary Open Angle Glaucoma or Ocular Hypertension. No intraocular surgeries besides cataract surgery.
15 participants (OPEN)
(212) 477-7540 Ext. 302
Home > Current Research > Clinical Trials in Ophthalmology > A Multi-center, double-masked, randomized, placebo-controlled, ascending dose study of INS115644 ophthalmic solution in subjects with bilateral ocular hypertension or early open angle glaucoma.